Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study

Author:

Bruun Marie1,Frederiksen Kristian S.1,Rhodius-Meester Hanneke F.M.2,Baroni Marta3,Gjerum Le1,Koikkalainen Juha4,Urhemaa Timo5,Tolonen Antti5,van Gils Mark5,Tong Tong6,Guerrero Ricardo6,Rueckert Daniel6,Dyremose Nadia1,Andersen Birgitte Bo1,Simonsen Anja H.1,Lemstra Afina2,Hallikainen Merja7,Kurl Sudhir7,Herukka Sanna-Kaisa7,Remes Anne M.7,Waldemar Gunhild1,Soininen Hilkka7,Mecocci Patrizia3,van der Flier Wiesje M.2,Lötjönen Jyrki4,Hasselbalch Steen G.1

Affiliation:

1. Department of Neurology, Danish Dementia Research Centre, University of Copenhagen, Rigshospitalet, Denmark

2. Alzheimer Center, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands

3. Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy

4. Combinostics Ltd., Tampere, Finland

5. VTT Technical Research Centre of Finland Ltd., Tampere, Finland

6. Institutes of Neurology and Healthcare Engineering, University College London, London, United Kingdom

7. Institute of Clinical Medicine, Neurology, University of Eastern Finland, Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland

Abstract

Background: Determining the underlying etiology of dementia can be challenging. Computer- based Clinical Decision Support Systems (CDSS) have the potential to provide an objective comparison of data and assist clinicians. Objectives: To assess the diagnostic impact of a CDSS, the PredictND tool, for differential diagnosis of dementia in memory clinics. Methods: In this prospective multicenter study, we recruited 779 patients with either subjective cognitive decline (n=252), mild cognitive impairment (n=219) or any type of dementia (n=274) and followed them for minimum 12 months. Based on all available patient baseline data (demographics, neuropsychological tests, cerebrospinal fluid biomarkers, and MRI visual and computed ratings), the PredictND tool provides a comprehensive overview and analysis of the data with a likelihood index for five diagnostic groups; Alzheimer´s disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia and subjective cognitive decline. At baseline, a clinician defined an etiological diagnosis and confidence in the diagnosis, first without and subsequently with the PredictND tool. The follow-up diagnosis was used as the reference diagnosis. Results: In total, 747 patients completed the follow-up visits (53% female, 69±10 years). The etiological diagnosis changed in 13% of all cases when using the PredictND tool, but the diagnostic accuracy did not change significantly. Confidence in the diagnosis, measured by a visual analogue scale (VAS, 0-100%) increased (ΔVAS=3.0%, p<0.0001), especially in correctly changed diagnoses (ΔVAS=7.2%, p=0.0011). Conclusion: Adding the PredictND tool to the diagnostic evaluation affected the diagnosis and increased clinicians’ confidence in the diagnosis indicating that CDSSs could aid clinicians in the differential diagnosis of dementia.

Funder

European Union’s Seventh Framework Programme for research, technological development and demonstration.

European Commission

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Neurology,Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3